Georgia Senate Bill 91 targets pharmacy benefits manager ownership regulations

Georgia State Legislature has introduced Senate Bill 91, a significant piece of legislation aimed at regulating the practices of pharmacy benefits managers (PBMs) in the state. Introduced on February 10, 2025, the bill seeks to address concerns regarding potential conflicts of interest that arise when PBMs own or have financial stakes in retail pharmacies.

The primary provision of Senate Bill 91 prohibits any pharmacy benefits manager from owning or having an ownership interest in a retail pharmacy. This measure is designed to ensure that PBMs operate independently and do not favor their own pharmacies over others, which could lead to unfair practices and limit consumer choice. Additionally, the bill clarifies that it will not affect any existing contracts that were in place before June 30, 2025, providing a transitional period for those involved.

The introduction of this bill has sparked notable debates among lawmakers and stakeholders in the healthcare industry. Proponents argue that the legislation is essential for promoting transparency and fairness in the pharmacy sector, potentially lowering drug costs for consumers. Critics, however, express concerns that such regulations could disrupt existing business models and limit the ability of PBMs to negotiate effectively on behalf of patients.

The implications of Senate Bill 91 extend beyond the immediate regulatory framework. If passed, the bill could reshape the landscape of pharmacy benefits management in Georgia, potentially influencing how PBMs operate nationwide. Experts suggest that this legislation may serve as a model for other states grappling with similar issues related to pharmacy ownership and patient access to medications.

As the bill moves through the legislative process, its future remains uncertain. Stakeholders are closely monitoring developments, as the outcome could have lasting effects on the healthcare system in Georgia and beyond. The next steps will involve further discussions and potential amendments as lawmakers seek to balance the interests of consumers, pharmacies, and pharmacy benefits managers.